Shandong Wit Dyne Health000915.SZValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Deeply Undervalued” zone.
As of Oct 19, 2026, Shandong Wit Dyne Health (000915.SZ) trades at a P/E of 13.60x, P/B of 2.19x, P/S of 3.37x, and a dividend yield of 10.24%.
Longitudinal percentile comparison: P/E sits at the 16th percentile over the trailing 10Y window (vs. 49th percentile over 3Y); P/B sits at the 9th percentile over the trailing 10Y window (vs. 23rd percentile over 3Y); P/S sits at the 46th percentile over the trailing 10Y window (vs. 64th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 7th percentile within its industry and the 11th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 10.24%, ranking at the 99th percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 7.1 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Shandong Wit Dyne Health operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: SHE: 000915 · SZSE: 000915 · 000915
Want the full picture on whether Shandong Wit Dyne Health (000915.SZ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 13.60 | ||||||
| P/B (MRQ) | 2.19 | ||||||
| P/S (TTM) | 3.37 | ||||||
| Dividend Yield | 10.24% | ||||||
| Buyback + Div Yield | 10.24% |